2VN-14947-13381
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 216 / MD
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GMY-26332-68311
Child or adolescent in my care · Female · 2022-06-26
7S5-18350-59839
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-06-17
Dose 1 — Pfizer-BioNTech
-
2021-06-21
Registered in v-safe
- 2021-06-21
- 2021-06-22
- 2021-06-23
- 2021-06-24
- 2021-07-01
-
2021-07-08
Dose 2 — Pfizer-BioNTech
- 2021-07-08
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
-
2021-07-22
Survey response — day 14, dose 2MedDRA: Cough, Office visit, Respiratory tract infection viral, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing, Upper-airway cough syndrome — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Sneezing, coughing, runny nose, post-nasal drip. Negative COVID test. Diagnosed by an MD with a respiratory virus (non-COVID). · Healthcare visit (other): Primary care physician. In personMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
- 2021-07-29
- 2021-08-05
- 2021-08-12
- 2021-08-19
- 2021-10-07
- 2022-01-06
-
2022-01-19
Dose 3 — Moderna
- 2022-07-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-17 | Pfizer-BioNTech | No |
| 2 | 2021-07-08 | Pfizer-BioNTech | No |
| 3 | 2022-01-19 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-22 | Unsuccessful |
Free text
Release 9 — day 14, dose 2
Symptoms: Sneezing, coughing, runny nose, post-nasal drip. Negative COVID test. Diagnosed by an MD with a respiratory virus (non-COVID).
Healthcare visit (other): Primary care physician. In person
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release